Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Open in API
Filings indexed 370 across all filing types
Latest filing 2024-08-05 Earnings Release
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
Oxford Nanopore: Singapore Precision Medicine prog
Earnings Release Classification · 99% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the concluding statement referencing 'Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' The content details a significant business development—a contract to sequence 10,000 genomes for Singapore's National Precision Medicine (NPM) programme. This is a material, non-financial operational update. Since it is a general regulatory announcement that doesn't fit specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), the most appropriate classification is the general regulatory filing category, RNS. FY 2024
2024-08-05 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document is a formal announcement released via RNS (Regulatory News Service) on August 1, 2024. The content explicitly details the 'Issue of Equity' (issuance of 308,172 ordinary shares) following option exercises and remuneration schemes, and subsequently announces the 'Total Voting Rights' as of July 31, 2024 (874,229,497 voting shares). This combination of announcing new share issuance and updating the total share capital/voting rights strongly aligns with the 'Share Issue/Capital Change' (SHA) definition. Although it is distributed via RNS, the core subject matter is a specific capital structure change, making SHA a more precise classification than the general RNS fallback.
2024-08-01 English
Investment from Novo Holdings and Equity Issue
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement dated August 1, 2024, detailing the successful completion of an 'Equity Issue of £80 million' involving a 'placing of new ordinary shares' and a subscription by Novo Holdings. It explicitly mentions the raising of gross proceeds, the placing price, the number of shares issued, and the expected admission to trading on the London Stock Exchange. This content directly relates to fundraising, capital structure changes, and the issuance of new shares for cash. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it is a regulatory announcement (RNS), the core subject matter is the financing activity itself, making CAP the most specific and appropriate classification over the general RNS fallback. The document is substantial and describes the transaction details, not just announcing that a report is available (ruling out RPA/RNS based on the 'Menu vs Meal' rule for short announcements).
2024-08-01 English
Investment from Novo Holdings and proposed placing
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement from Oxford Nanopore Technologies plc, dated July 31, 2024. The core content announces an 'equity issue to raise aggregate gross proceeds of approximately £75 million' via a strategic investment (Subscription) from Novo Holdings and a placing to institutional investors. This clearly describes a capital raising or financing activity. Based on the definitions, the most appropriate code is 'CAP' (Capital/Financing Update). Although it is distributed via RNS, the specific nature of the announcement (equity issue/placing) makes CAP more precise than the general RNS fallback.
2024-07-31 English
Half Year Trading Update
Earnings Release Classification · 100% confidence The document is titled 'Half Year Trading Update' and provides preliminary financial figures (revenue, gross margin) for the six months ended 30 June 2024, ahead of the full results release on September 3rd. It reaffirms full-year guidance. This content structure—a brief update on recent performance and outlook before the official comprehensive report—is characteristic of an Earnings Release (ER). Although it covers a half-year period, it is an 'update' rather than the full, detailed 'Interim Report' (IR). The presence of the RNS Number and the LSE distribution footer confirms it is a regulatory announcement, but the specific content points directly to an earnings preview. Therefore, 'ER' is the most appropriate classification. H1 2024
2024-07-24 English
Plasmidsaurus collaboration and contract expansion
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 4347X' and contains a press release format announcing a strategic collaboration and contract expansion between Oxford Nanopore Technologies plc and Plasmidsaurus. This type of announcement, which is not a formal financial report (like 10-K or IR), a specific shareholder vote result (DVA), or a management change (MANG), fits best under the general category for regulatory announcements distributed via the RNS system. Since it is a general corporate update distributed through the RNS service and doesn't fit the more specific categories like DIV, CAP, or ER, the most appropriate classification is Regulatory Filings (RNS). The document length is moderate, but the content is purely an announcement, not the full report itself.
2024-07-23 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.